Skip to main content
. 2016 May 16;2016:3794738. doi: 10.1155/2016/3794738

Table 3.

Detection rate MRI/US fusion targeted biopsy by size of ROI (n = 148).

Lesion size Freq. Any PCa Sign PCa
MRI/US Fusion targeted biopsy
<5 mm 22 11 (50%) 7 (32%)
5–9 mm 93 39 (42%) 26 (28%)
≥10 mm 45 28 (62%) 25 (56%)

Freq. = frequency, PCa = prostate cancer, Sign = significant, and ROI = region of interest.